Rapid medical countermeasure response to infectious diseases [electronic resource] : enabling sustainable capabilities through ongoing public- and private-sector partnerships : workshop summary / Theresa Wizemann, Megan Reeve Snair, and Jack Herrmann, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation ; Forum on Microbial Threats, Board on Health Sciences Policy, Board on Global Health, Institute of Medicine, The National Academies of Sciences, Engineering, Medicine.

"Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermea...

Full description

Saved in:
Bibliographic Details
Main Author: Wizemann, Theresa M. (rapporteur.)
Corporate Authors: Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events (Issuing body)
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation (Issuing body)
Institute of Medicine (U.S.). Forum on Microbial Threats (Issuing body)
Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases (Workshop)
Other Authors: Snair, Megan Reeve (rapporteur.)
Herrmann, Jack (rapporteur.)
Language:English
Published: Washington, D.C. : The National Academies Press, [2016]
Subjects:
Genre:
Online Access:
Variant Title:
Enabling sustainable capabilities through ongoing public- and private-sector partnerships : workshop summary
Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary
Format: Electronic Conference Proceeding eBook

MARC

LEADER 00000cam a22000003i 4500
001 ebs7458107e
003 EBZ
006 m o d ||||||
007 cr|unu||||||||
008 161117t20162016dcua ob 100 0 eng d
020 |z 9780309378611 
020 |a 9780309378628 (online) 
020 |a 9780309378642 (online) 
020 |a 9780309378659 (online) 
035 |a (EBZ)ebs7458107e 
040 |a YDXCP   |b eng   |d EBZ 
042 |a lccopycat 
050 0 0 |a RA643  |b .W59 2016 
100 1 |a Wizemann, Theresa M.,  |e rapporteur. 
245 1 0 |a Rapid medical countermeasure response to infectious diseases  |h [electronic resource] :  |b enabling sustainable capabilities through ongoing public- and private-sector partnerships : workshop summary /  |c Theresa Wizemann, Megan Reeve Snair, and Jack Herrmann, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation ; Forum on Microbial Threats, Board on Health Sciences Policy, Board on Global Health, Institute of Medicine, The National Academies of Sciences, Engineering, Medicine. 
246 3 0 |a Enabling sustainable capabilities through ongoing public- and private-sector partnerships : workshop summary 
246 2 |a Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary 
264 1 |a Washington, D.C. :  |b The National Academies Press,  |c [2016] 
264 4 |c ©2016 
500 |a Report of the Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases: an Institute of Medicine Workshop which took place at the National Academy of Sciences Building in Washington, D.C. on March 26-27, 2015. 
504 |a Includes bibliographical references (pages 105-107). 
505 0 |a A wake-up call: the 2014 Ebola outbreak response -- Preparedness as an issue of national security -- Rapid development of Ebola vaccines -- Influenza risk assessment and pandemic preparedness -- Developing MCMs for coronaviruses -- Sustainable business models to ensure rapid and nimble responses -- Supporting MCM development across threats and funding cycles. 
520 1 |a "Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States has been extremely challenging. Interest and momentum peak during a crisis and wane between events, and there is little interest in disease threats outside the United States until they impact people stateside. On March 26 and 27, 2015, the Institute of Medicine convened a workshop in Washington, DC to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. Public- and private-sector stakeholders examined recent efforts to prepare for and respond to outbreaks of Ebola Virus Disease, pandemic influenza, and coronaviruses from policy, budget, and operational standpoints. Participants discussed the need for rapid access to MCM to ensure national security and considered strategies and business models that could enhance stakeholder interest and investment in sustainable response capabilities. This report summarizes the presentations and discussions from this workshop"--  |c Publisher's description. 
650 0 |a Emerging infectious diseases  |x Treatment  |v Congresses. 
650 0 |a Disaster medicine  |v Congresses. 
650 0 |a Medical emergencies  |v Congresses. 
650 0 |a Public health  |v Congresses. 
700 1 |a Snair, Megan Reeve,  |e rapporteur. 
700 1 |a Herrmann, Jack,  |e rapporteur. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Medical and Public Health Preparedness for Catastrophic Events.  |e issuing body. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Drug Discovery, Development, and Translation.  |e issuing body. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Microbial Threats.  |e issuing body. 
711 2 |a Enabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases (Workshop)  |d (2015 :  |c Washington, D.C.) 
773 0 |t ProQuest Ebook Central - Academic Complete   |d ProQuest Info & Learning Co 
773 0 |t National Academies Press   |d National Academy of Sciences 
773 0 |t EBSCO eBooks   |d EBSCO 
773 0 |t NCBI Bookshelf   |d NCBI 
773 0 |t eBook Academic Collection (EBSCOhost) – North America   |d EBSCO 
776 1 |t Rapid medical countermeasure response to infectious diseases  |w (OCoLC)ocn926823041  |w (DLC)2016427924 
856 4 0 |y Access Content Online(from ProQuest Ebook Central - Academic Complete)  |u https://ezproxy.msu.edu/login?url=https://ebookcentral.proquest.com/lib/michstate-ebooks/detail.action?docID=4416302  |z ProQuest Ebook Central - Academic Complete: 2016 
856 4 0 |y Access Content Online(from National Academies Press)  |u https://nap.nationalacademies.org/21809  |z National Academies Press: 2016 
856 4 0 |y Access Content Online(from EBSCO eBooks)  |u https://ezproxy.msu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1083255  |z EBSCO eBooks: 2016 
856 4 0 |y Access Content Online(from NCBI Bookshelf)  |u https://ezproxy.msu.edu/login?url=https://www.ncbi.nlm.nih.gov/books/NBK344339  |z NCBI Bookshelf: 2016 
856 4 0 |y Access Content Online(from eBook Academic Collection (EBSCOhost) – North America)  |u https://ezproxy.msu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1083255  |z eBook Academic Collection (EBSCOhost) – North America: 2016